Why Farbe Firma is the Leading Injectable Manufacturer in Saint Vincent and the Grenadines
Why Farbe Firma is the Leading Injectable Manufacturer in Saint Vincent and the Grenadines
Last Updated: 23 September 2026
TL;DR: Saint Vincent and the Grenadines has a commenced Pharmacy Act, proclaimed into force on 28 December 2004. What it requires of an importer is genuinely contested: the health ministry's own profile with PAHO says the law requires marketing authorisation, while the Caribbean Public Health Agency lists six CARICOM countries with legal authorisation requirements and does not include this one. Both are official documents and both are printed here. What is visibly operating is the import licence and pooled regional procurement.
Key Takeaways
The Pharmacy Act No. 54 of 2002 was assented to on 30 December 2002 and proclaimed into force on 28 December 2004, so enactment and commencement are both settled. The statute's text is not published online and we could not obtain it, which means we cannot say whether it names foreign regulators at all. We therefore say neither that India's CDSCO is recognised there nor that it is excluded.
Two official accounts conflict. The Ministry of Health and PAHO's joint country profile states that legal provisions require marketing authorisation, and CARICOM's regional assessment cites section 27(6) to the same effect. CARPHA's 2020 guidance instead names six CARICOM states with legal authorisation requirements and this country is not among them. We report the conflict and do not resolve it.
The operating control point is the import licence rather than a product dossier. Authorisation is required to import medicines, and importers, wholesalers and distributors are all licensed. The general trade regulations are a separate matter: we read their schedules in full and they contain no pharmaceutical heading, so the medicines licence is a health instrument and not a customs one.
Public-sector medicines are bought mainly through the OECS Pharmaceutical Procurement Service, with Central Medical Stores running the supply chain. That prequalification form asks for a certificate of GMP or ISO certification, names no issuing authority anywhere, and marks a WHO-format certificate optional, which makes it the route a WHO-GMP certified Indian manufacturer can actually use.
Introduction: What an Injectable Manufacturer in Saint Vincent Is Actually Being Asked For
The instinct with a market of roughly a hundred thousand people is to assume medicines move on trust and paperwork follows later. That is not the position here. There is a Pharmacy Act, proclaimed into force in December 2004, vesting authority over medicines in a Pharmacy Council. The harder question is what that Act asks of a foreign manufacturer today, and on that the official record does not speak with one voice.
The health ministry's own profile, prepared with PAHO, records that legal provisions require marketing authorisation. The same document records that registration is not actually being performed, and says the country lacks the capacity to establish and enforce it. CARPHA, meanwhile, lists the CARICOM states with legal authorisation requirements and this one is absent from it. A requirement written in a statute and a requirement that bites today are different things, and we will not pretend to know which applies.
What Sets a World-Class Injectable Manufacturer in Saint Vincent's Supply Chain Apart
Separate the layers before quoting anyone a pathway. At the site layer, nothing we could find gives this country power to inspect or license a factory abroad. At the product layer the position is the contested one described above, and because the statute's text is not available we cannot tell you what a dossier would have to contain or whose approvals would count. At the importer layer, by contrast, the record is clear and consistent across sources.
Authorisation is required to import medicines, and importers, wholesalers and distributors must be licensed. The regional assessment describes a statutory schedule of drugs importable only under a licence from the Pharmacy Council, and reports that any pharmaceutical establishment must be under the charge of a registered pharmacist. We have not read that section ourselves, so we flag it as reported rather than verified, but it points firmly towards a locally established licensee being necessary rather than optional.
Quality Systems Behind Every Sterile Injectable Batch
Farbe Firma manufactures under WHO-GMP certification in Gujarat, India, with ISO Class 5 aseptic filling zones under continuous environmental monitoring. We could not locate any schedule of pharmacopoeias for this market in either direction, so rather than guess at a house standard we write specifications to the compendium the buyer names. Batch release rests on HPLC and GC assay and impurity work, Karl Fischer, LAL endotoxin testing, sterility, particulate matter and container-closure integrity.
Stability is designed for a hot, humid island climate rather than a temperate default, running to ICH Q1A with photostability under ICH Q1B where the molecule requires it. Freight reality is planned in: long routes into the Eastern Caribbean consume shelf life, so remaining life at delivery is a design input and not an afterthought, and cold-chain presentations ship in validated configurations with temperature records. Dossiers are assembled in CTD and ACTD format.
Why Farbe Firma is the Trusted Injectable Manufacturer in Saint Vincent for Global Buyers
Farbe Firma is a WHO-GMP certified sterile injectable manufacturer and CDMO in Gujarat, India, exporting to more than 30 countries. In a market where the regulatory question is genuinely open, the useful supplier is the one who tells you that plainly and then meets the requirement that is not in doubt. The pooled procurement route asks for a certificate of GMP or ISO certification and names no issuing authority, and it treats a WHO-format certificate as optional rather than mandatory.
We are equally direct about where an Indian certificate does less work than a buyer might hope. CARPHA's Caribbean Regulatory System runs an agency-specific pathway whose published list of forty-one reference authorities does not include CDSCO, and CARPHA is explicit that its output is only a recommendation. That is not a closed door to Indian manufacturing: on CARPHA's own list of recommended products, most entries were issued to manufacturers at Indian addresses, many of them injectables, reaching it through approvals from other reference authorities or through WHO Prequalification.
Two further distinctions are worth stating rather than glossing. WHO's December 2025 transitional listing records India's CDSCO at maturity level 3 with a scope column reading vaccines, where Ghana, Nigeria and Tanzania carry medicines, so a maturity-level argument does no work for a small-molecule injectable. On funding, the Global Fund's 2026 list records this country as upper-middle-income yet eligible for HIV and tuberculosis through an exception for IDA-eligible small states, and never Gavi-eligible. Eligibility is not an allocation and not a grant.
Explore Farbe Firma: Products / Global Reach / About Us
Frequently Asked Questions (FAQ)
Does Saint Vincent and the Grenadines register medicines?
Official sources disagree. The Pharmacy Act No. 54 of 2002 was proclaimed into force on 28 December 2004, and both the health ministry's profile with PAHO and CARICOM's regional assessment describe it as requiring marketing authorisation. CARPHA's 2020 guidance instead names six CARICOM countries with legal authorisation requirements and this is not one of them. The same PAHO profile records that registration is not being performed in practice. Put the question to the Pharmacy Council in writing.
Is India's CDSCO recognised for medicines imported into the country?
We do not know, and we will not guess in either direction. The text of the Pharmacy Act is not published online and we could not obtain it, so we cannot say whether it names foreign regulators at all. Absence of evidence that CDSCO is listed is not evidence that it is excluded, and the reverse holds equally. The regional procurement route names no issuing authority.
Does the OECS procurement route accept an Indian WHO-GMP certificate?
On the face of the current prequalification form, yes. It asks a manufacturer to attach a certificate of GMP or ISO certification, names no issuing authority anywhere in the document, and marks a WHO-format Certificate of Pharmaceutical Product as optional. It also routes new manufacturers through an authorised distributor, which is a commercial step worth solving early. Prequalified suppliers who skip two consecutive tenders are removed from the directory.
Who can hold an import licence, and can a foreign manufacturer?
Authorisation is required to import medicines, and importers, wholesalers and distributors are licensed. Whether a foreign manufacturer may hold such a licence itself we could not establish, so we will not assert that it cannot. The reported requirement that any pharmaceutical establishment be under the charge of a registered pharmacist makes a locally established partner the likely practical answer, and qualifying that partner is the first step of any entry plan.
Is donor funding available for medicines in this market?
Partly, and it is narrowing. The Global Fund's 2026 eligibility list records the country as upper-middle-income and eligible for HIV and tuberculosis, not malaria, through a published exception for IDA-eligible small states. The multi-country Caribbean HIV component that names it sits on a Grant Cycle 8 transition timeline, and it appears on the list of countries never eligible for Gavi support. Eligibility is not an allocation, and we identified no current grant.
Technically Reviewed By: Maulik Sudani (Technical Expert) | Jignasu Sudani (Technical Expert), Farbe Firma Pvt Ltd, Gujarat, India.
Farbe Firma Pvt Ltd - WHO-GMP certified sterile injectable manufacturer and CDMO, Gujarat, India. ISO Class 5 aseptic filling, CTD/ACTD dossiers, exporting to 30+ countries. director@farbefirma.orgRequest a Quote / View Products / Blog
Comments